{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:29:56Z","timestamp":1778660996106,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2010,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cross\u2010cultural adaptation and psychometric assessment of the Scales for Outcomes in Parkinson's Disease\u2010Autonomic questionnaire (SCOPA\u2010AUT) Brazilian Portuguese version. 150 consecutive Parkinson's disease (PD) patients were evaluated by means of the SCOPA\u2010motor scale (SCOPA\u2010M), SCOPA\u2010cognition (SCOPA\u2010COG), Hoehn and Yahr staging (H&amp;Y), nonmotor symptoms scale (NMSS), PD questionnaire (PDQ\u201039), and SCOPA\u2010AUT. The following psychometric attributes were explored: acceptability, scaling assumptions, reliability, precision, and construct validity. Patients' age (mean \u00b1 standard deviation) was 63.1 \u00b1 11.1 years (56.7% men; duration of disease, 8.7 \u00b1 5.3 years; median H&amp;Y, 2). Mean SCOPA\u2010AUT was 23.0 \u00b1 11.2. SCOPA\u2010AUT did not show floor or ceiling effect. As a whole, the SCOPA\u2010AUT item\u2010domain correlation was satisfactory, except for items 2 (Saliva), 7 (Faecal incontinence), 16 (Syncope), and 19 (Cold intolerance) (|r<jats:sub>S<\/jats:sub>| = 0.03\u20130.32). Internal consistency was adequate, except for thermoregulatory and cardiovascular domains (alpha coefficients, 0.56 and 0.63, respectively). Intraclass correlation coefficient for the total score was 0.71, whereas weighted kappa for individual items ranged from 0.15 to 0.71 (only items 4 and 7 were &lt;0.40). Standard error of measurement was 6.04. The SCOPA\u2010AUT total score correlated closely with the NMSS total score (r<jats:sub>S<\/jats:sub> = 0.65) and PDQ\u201039 Summary Index (r<jats:sub>S<\/jats:sub> = 0.61) and at a moderate level with H&amp;Y staging (r<jats:sub>S<\/jats:sub> = 0.35) and SCOPA\u2010MS total score (r<jats:sub>S<\/jats:sub> = 0.39) (all r<jats:sub>S<\/jats:sub> values, <jats:italic>P<\/jats:italic> &lt; 0.0001). Correlation of SCOPA\u2010AUT with SCOPA\u2010COG was weak. SCOPA\u2010AUT significantly increased as the H&amp;Y stage increased (Kruskal\u2010Wallis, <jats:italic>P<\/jats:italic> &lt; 0.0001). The SCOPA\u2010AUT Brazilian Portuguese version is an acceptable, reliable, and valid questionnaire to evaluate autonomic dysfunction in PD. \u00a9 2009 Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.22882","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T15:50:28Z","timestamp":1259077828000},"page":"205-212","source":"Crossref","is-referenced-by-count":24,"title":["Psychometric properties of the SCOPA\u2010AUT Brazilian Portuguese version"],"prefix":"10.1002","volume":"25","author":[{"given":"Francisco Javier","family":"Carod\u2010Artal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciola","family":"da Silveira Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wladimir","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Martinez\u2010Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1099"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-005-0072-6"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1105-z"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000266593.50534.e8"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20153"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.017509"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21596"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000091864.39702.1C"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02260863"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21769"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21216"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01593882"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00085-7"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02310555"},{"key":"e_1_2_7_18_2","volume-title":"Psychometric theory","author":"Nunnally JC","year":"1994"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199905000-00006"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015291021312"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.10.773"},{"key":"e_1_2_7_23_2","first-page":"49","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"Juniper EF","year":"1996"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.5.962"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(01)00052-9"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-005-0253-z"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20844"},{"key":"e_1_2_7_28_2","first-page":"360","article-title":"A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology","volume":"42","author":"ELEP Group","year":"2006","journal-title":"Rev Neurol"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-007-0410-7"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0909-6"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.22882","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.22882","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.22882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:48:15Z","timestamp":1760950095000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.22882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1,30]]}},"alternative-id":["10.1002\/mds.22882"],"URL":"https:\/\/doi.org\/10.1002\/mds.22882","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,30]]}}}